119 related articles for article (PubMed ID: 24962841)
1. Characterization of transfusion-derived iron deposition in childhood cancer survivors.
Ruccione KS; Wood JC; Sposto R; Malvar J; Chen C; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1913-9. PubMed ID: 24962841
[TBL] [Abstract][Full Text] [Related]
2. Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors.
Ruccione KS; Mudambi K; Sposto R; Fridey J; Ghazarossian S; Freyer DR
Pediatr Blood Cancer; 2012 Oct; 59(4):697-702. PubMed ID: 22190481
[TBL] [Abstract][Full Text] [Related]
3. Iron Overload in Survivors of Childhood Cancer.
Trovillion EM; Schubert L; Dietz AC
J Pediatr Hematol Oncol; 2018 Jul; 40(5):396-400. PubMed ID: 28562518
[TBL] [Abstract][Full Text] [Related]
4. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia.
Unal S; Cetin M; Hazirolan T; Yildirim G; Meral A; Birbilen A; Karabulut E; Aytac S; Tavil B; Kuskonmaz B; Tuncer M; Gumruk F
Leuk Res; 2014 Aug; 38(8):882-5. PubMed ID: 24933623
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
6. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Liver Iron Content by Magnetic Resonance Imaging in Children with Acute Lymphoblastic Leukemia after Cessation of Treatment.
Acar S; Gözmen S; Bayraktaroğlu S; Acar SO; Tahta N; Aydınok Y; Vergin RC
Turk J Haematol; 2020 Nov; 37(4):263-270. PubMed ID: 32077272
[TBL] [Abstract][Full Text] [Related]
8. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age.
Berdoukas V; Nord A; Carson S; Puliyel M; Hofstra T; Wood J; Coates TD
Am J Hematol; 2013 Nov; 88(11):E283-5. PubMed ID: 23861216
[TBL] [Abstract][Full Text] [Related]
9. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
Rascon J; Rageliene L; Stankeviciene S; Palionis D; Tamosiunas AE; Valeviciene N; Zvirblis T
Eur J Pediatr; 2014 Sep; 173(9):1137-46. PubMed ID: 24659311
[TBL] [Abstract][Full Text] [Related]
10. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
11. Insidious iron burden in pediatric patients with acute lymphoblastic leukemia.
Eng J; Fish JD
Pediatr Blood Cancer; 2011 Mar; 56(3):368-71. PubMed ID: 21072815
[TBL] [Abstract][Full Text] [Related]
12. Iron Overload in Survivors of Childhood Cancer.
Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
[TBL] [Abstract][Full Text] [Related]
13. Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition.
Papadodima S; Masia R; Stone JR
Cardiovasc Pathol; 2019; 40():7-11. PubMed ID: 30763826
[TBL] [Abstract][Full Text] [Related]
14. Incidentally Detected Transfusion-associated Iron Overload in 3 Children After Cancer Chemotherapy.
Kuo DJ; Bhagia P
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e164-e166. PubMed ID: 29300241
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in children undergoing cancer treatments.
de Ville de Goyet M; Moniotte S; Robert A; Dupont S; Vermylen C; Veyckemans F; Brichard B
Pediatr Blood Cancer; 2013 Dec; 60(12):1982-7. PubMed ID: 23897631
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
[TBL] [Abstract][Full Text] [Related]
17. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
Shander A; Sazama K
Transfusion; 2010 May; 50(5):1144-55. PubMed ID: 20088842
[TBL] [Abstract][Full Text] [Related]
18. Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia.
Butt NM; Clark RE
Bone Marrow Transplant; 2003 Nov; 32(9):909-13. PubMed ID: 14561992
[TBL] [Abstract][Full Text] [Related]
19. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
20. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
